This is an erratum to a previously published articles available here: http://discovery.ucl.ac.uk/1508429

Cragg, WJ

Cromarty, B

Gafos, M

Hanley, B

Scott, K

South, A

Stephens, R

Sturgeon, K

Teera, J

Tweed, CD

Vale, CL

UCL Discovery

South et al. Trials  (2016) 17:440 DOI 10.1186/s13063-016-1567-yERRATUM Open AccessErratum to: ‘Models and impact of patientand public involvement in studies carriedout by the Medical Research CouncilClinical Trials Unit at University CollegeLondon: findings from ten case studies’Annabelle South1*, Bec Hanley1, Mitzy Gafos1, Ben Cromarty1,2, Richard Stephens1,3, Kate Sturgeon1, Karen Scott1,William J. Cragg1, Conor D. Tweed1, Jacqueline Teera1 and Claire L. Vale1ErratumUnfortunately, the original version of this article [1]contained an error. Box 1 was omitted from the HTMLversion however the PDF version is fine and Box 1 can beseen there. To correct this we have included Box 1 belowand will also be doing an update.* Correspondence: A.south@ucl.ac.uk1Medical Research Council Clinical Trials Unit at UCL, Aviation House, 125Kingsway, London WC2B 6NH, UKFull list of author information is available at the end of the article© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, andreproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link tothe Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.South et al. Trials  (2016) 17:440 Page 2 of 2Box 1 Lessons learnt: the views of researchers andpatient representativesWho to involve:● Enthusiasm for research was considered an essential characteristic forpatient representatives. There was less agreement over what otherskills or attributes were essential.● Patient representatives who had scientific backgrounds (in a variety ofdifferent areas of science) felt that helped them to adapt to thelanguage and processes of medical research● Trial participants can provide unique insights because they are goingthrough the trial. This may be very valuable.● Some patient and community organisations can help to matchinterested people with research with researchers, based ontheir relevant skills and experience and the focus of theresearch.Providing support:● Examples of support provided by researchers, that PPI representativesfound to be useful include (but are not limited to):○ Taking time to explain things to patient representatives○ Helping patient representatives to prepare for meetings○ Organising visits to trial sites to see how the trial runs○ Providing a glossary of terms (including study-specific ones) thatmay be used.○ Remembering that patient representatives may be personallyaffected by discussions.○ Helping PPI representatives develop a better understanding ofstatistical concepts, especially at the analysis stage.● Existing patient groups and community organisations can act as avital bridge between researchers and patient and/or communityrepresentatives● Building on existing community structures (such as communitygroups, work places or traditional leadership groups) rather thantrying to create new ones can help to encourage communityengagement (see MDP interview notes for more details)● Having more than one PPI representative on a group or committee isimportant because:○ They can help to support each other○ It can help with the continuity of involvement, in particular wherethe study takes place over a prolonged period of time, or wherethere may be high turnover of patient representatives○ It can help with diversity of involvement, in particular where thereis considerable diversity in the population affected.Types of involvement● Integrating PPI at a cross-study or Unit level (e.g. Protocol ReviewCommittee, or a panel of patient/community representatives toadvise on several studies in a disease area) may facilitate PPI in thedevelopment and early phases of a study.● It can be helpful to involve people who are already well known andhave strong links to, patient groups/the community, particularly forinvolvement in more formal trial committees.● Involving patients on data monitoring committees can behelpful, especially where side effects are an issue, as they cangive a patient’s perspective on the balance between risks andbenefits.● Using a mix of PPI models, i.e. having different types of involvementat different stages of a trial and with different groups and individuals,may enhance the potential impacts of PPI.Author details1Medical Research Council Clinical Trials Unit at UCL, Aviation House, 125Kingsway, London WC2B 6NH, UK. 2North Yorkshire AIDS Action, 20 StSaviourgate, York YO1 8NN, UK. 3National Cancer Research InstituteConsumer Forum, Angel Building, 407 St John Street, London EC1V 4AD, UK.Received: 23 August 2016 Accepted: 23 August 2016Reference1. South A, Hanley B, Gafos M, Cromarty B, Stephens R, Sturgeon K, Scott K,Cragg WJ, Tweed CD, Teera J, Vale CL. Models and impact of patient andpublic involvement in studies carried out by the Medical Research CouncilClinical Trials Unit at University College London: findings from ten casestudies. Trials. 2016;17:376.•  We accept pre-submission inquiries •  Our selector tool helps you to find the most relevant journal•  We provide round the clock customer support •  Convenient online submission•  Thorough peer review•  Inclusion in PubMed and all major indexing services •  Maximum visibility for your researchSubmit your manuscript atwww.biomedcentral.com/submitSubmit your next manuscript to BioMed Central and we will help you at every step:

Erratum to: Models and impact of patient and public involvement in studies carried out by the Medical Research Council Clinical Trials Unit at University College London: findings from ten case studies (vol 17, 376, 2016)

http://discovery.ucl.ac.uk/1516882/1/art%253A10.1186%252Fs13063-016-1567-y.pdf

Erratum to: Models and impact of patient and public involvement in studies carried out by the Medical Research Council Clinical Trials Unit at University College London: findings from ten case studies (vol 17, 376, 2016)

Abstract

Similar works

Full text

Available Versions

UCL Discovery